Elysium Health and the University of Oxford Solve a Big Piece of the Brain Aging Puzzle
Here’s why we partnered with the University of Oxford to develop Matter, a product to support brain health during the aging process. Details on the VITACOG study, which powers the B-vitamin complex in Matter:
- LocationConducted at the University of Oxford
- Participants168 adults over 70 years of age with mild cognitive concerns, two-year clinical trial
- ProtocolDouble-blind, placebo-controlled, randomized—the “gold standard” in studies
- ResultsThe B-vitamin complex supports brain health, significantly reducing age-related brain atrophy. Individual results may vary and not everyone may achieve results
Result: Supports Brain Health, Significantly Slowing Brain Atrophy
Over the course of two years, the B-vitamin complex in Matter measurably slowed the rate of brain atrophy by 30%, and in certain brain regions involved in visuospatial learning and spatial long-term memory, the rate of grey matter atrophy was slowed by an average of 86%.
Get Started With Matter
You can take charge of your brain health. It’s time to take Matter into your own hands.